Palexia (Tapentadol Hydrochloride)

Tapentadol Hydrochloride, the active ingredient in Palexia, is an opioid analgesic presented as a strength/form for oral use. It is indicated for the management of moderate to severe acute pain in adults. GNH USA supplies Palexia as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Palexia as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Tapentadol Hydrochloride is used to treat pain that involves the central nervous system pathways.

- Acute postoperative pain: Provides effective relief when non‑opioid analgesics are insufficient. - Chronic musculoskeletal pain: Helps reduce pain intensity in conditions such as osteoarthritis. - Cancer‑related pain: Contributes to overall pain control as part of a multimodal regimen. - Neuropathic pain associated with diabetic peripheral neuropathy: Alleviates burning and shooting sensations. - Severe traumatic injury pain: Offers strong analgesia for major trauma patients.

Tapentadol Hydrochloride may present a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea - Constipation - Dizziness - Headache - Somnolence - Dry mouth

Serious or Rare Side Effects: - Respiratory depression - Seizure  - Severe hypotension  - Allergic reaction  - Opioid dependence  - adrenal ??

Pal… 

-                              ... ... ...  ");

    ....  ...